calfkicker.com
Ya, he says things are gonna get really really tight on retatrutide, I believe it, stocking up whenever I can.Andrew Huberman Slams ‘Peptides’ Media Coverage as a “Dog’s Breakfast,” Says Pharma Divide Fuels Black and Gray Markets
Stanford neuroscientist Andrew Huberman has taken aim at mainstream media coverage of peptide therapeutics, calling the broad categorization of these “a dog’s breakfast” that conflates peptides with vastly different regulatory…
It's true, but all this fear-mongering (and loopholes too) are making the sourcing a real pain in the ass.
Andrew Huberman Slams ‘Peptides’ Media Coverage as a “Dog’s Breakfast,” Says Pharma Divide Fuels Black and Gray Markets
Stanford neuroscientist Andrew Huberman has taken aim at mainstream media coverage of peptide therapeutics, calling the broad categorization of these “a dog’s breakfast” that conflates peptides with vastly different regulatory…
The CEO of Eli Lilly is David Ricks. His total compensation in 2025 was $36.7 million. The largest shareholders are Vanguard and BlackRock. Eli Lilly is the richest pharma company in the world by market cap. ($930 Billion)
Dave Ricks - Chair/CEO at Eli Lilly and Company | LinkedIn
Chair/CEO at Eli Lilly and Company · A Lilly veteran for more than 25 years, with experience in marketing, sales, drug development and international operations. I became CEO in January 2017 and was elected chair of the company’s board of directors effective June 2017. I serve on the board of...www.linkedin.com
He wants your vials! You're costing him money!
Sorry I wasted your time.
